• A new toolbox allows engineering genomes without CRISPR

    Thursday February 8th 2024

  • flanders.bio applauds New Genomic Techniques European Parliament vote, while issuing cautionary note

    Thursday February 8th 2024

  • Biotalys enters into academic collaborations with key scientific leaders in Europe and U.S.

    Thursday February 8th 2024

  • Belgian researchers provide a strong boost to sustainable agriculture

    Thursday February 1st 2024

  • Galapagos completes transaction to transfer Jyseleca® business to Alfasigma

    Thursday February 1st 2024

  • BioLizard announces the appointment of André van de Sande as Chairman of the Board

    Tuesday January 30th 2024

  • Sequana Medical announces FDA acceptance for substantive review of the Premarket Approval application for alfapump® in recurrent or refractory ascites due to liver cirrhosis

    Monday January 29th 2024

  • Fruit flies provide insights into the hidden world of sleep

    Tuesday January 23rd 2024

  • Your news here?

  • Protealis secures EUR 22 million in oversubscribed B-round funding to propel sustainable plant protein seed solutions

    Tuesday January 23rd 2024

  • flanders.bio celebrates 20 years of catalysing growth in life sciences

    Tuesday January 23rd 2024

  • Sequana Medical announces DSMB approval to start randomized MOJAVE cohort – US Phase 1/2a study of DSR® 2.0 for treatment of heart failure

    Tuesday January 23rd 2024


Strategic Partners